• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY MEGATRON; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY MEGATRON; CORONARY DRUG-ELUTING STENT Back to Search Results
Lot Number 0032443538
Medical Device Problem Codes Break (1069); Material Deformation (2976)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/16/2024
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that shaft break occurred.The stenosed target lesion was located in the left anterior descending artery.A 3.50 x 16mm synergy megatron drug-eluting stent was selected for treatment.However, during insertion of the device over the wire, the distal shaft bent, and broke.The device was removed, and the procedure was completed with another of the same device.There were no patient complications nor injuries reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr.Synergy megatron mr us 3.50 x 16mm stent delivery system was returned to the complaint investigation site (cis).Visual, tactile and microscopic analysis was performed on the device.Multiple hypotube kinks were identified along the shaft of the device.A visual and tactile examination of the outer and inner lumen and mid-shaft section found a break in the midshaft at the laser cut region at 109.7 cm distal to the distal end of the strain relief.The break was contained in the midshaft.There was no sign of damage, stretching or lifting of the stent struts.Balloon cones were reviewed, and no issues were noted.Balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.No signs of movement, stent was set between the proximal and distal markerbands.An examination of the proximal and distal markerband identified no issues.Bumper tip showed no signs of distal tip damage.No other device issues were identified during returned product analysis.
 
Event or Problem Description
It was reported that shaft break occurred.The stenosed target lesion was located in the left anterior descending artery.A 3.50 x 16mm synergy megatron drug-eluting stent was selected for treatment.However, during insertion of the device over the wire, the distal shaft bent, and broke.The device was removed, and the procedure was completed with another of the same device.There were no patient complications nor injuries reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY MEGATRON
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18778253
Report Number2124215-2024-10774
Device Sequence Number19914620
Product Code NIQ
UDI-Device Identifier08714729985617
UDI-Public08714729985617
Combination Product (Y/N)Y
Initial Reporter StateOH
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/03/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/05/2025
Device Lot Number0032443538
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 02/16/2024
Supplement Date Received by Manufacturer03/27/2024
Initial Report FDA Received Date02/26/2024
Supplement Report FDA Received Date04/03/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/06/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-